![Patrick M. O'Connor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick M. O'Connor
Fundador en
Selexagen Therapeutics, Inc.
.
Perfil
Patrick M.
O'Connor is the founder of Selexagen Therapeutics, Inc. (founded in 2009) where he currently holds the title of Director & Chief Scientific Officer.
He has also held former positions at Agouron Pharmaceuticals LLC as Head-Oncology Research Division in 2013, Pfizer Inc. as Vice President & Head-Global Oncology Research, Ignyta Operating, Inc. as Chief Scientific Officer & Senior VP-Research in 2013, National Cancer Institute as a Fogarty International Visiting Scientist, Ardea Biosciences, Inc. as Chief Scientific Officer & Senior VP-Research, Aravive Biologics, Inc. as VP, Head-Oncology Research & Development, and Ignyta, Inc. as Chief Scientific Officer, SVP & Head-Research from 2013 to 2014.
Dr. O'Connor obtained a doctorate degree from The University of Manchester.
Cargos activos de Patrick M. O'Connor
| Empresas | Cargo | Inicio |
|---|---|---|
Selexagen Therapeutics, Inc.
 Selexagen Therapeutics, Inc. Selexagen Therapeutics, Inc. is a private company based in San Diego, CA. The company was founded by Jean-Michel Vernier, Patrick M. O'Connor. | Fundador | 01/01/2009 |
Antiguos cargos conocidos de Patrick M. O'Connor.
| Empresas | Cargo | Fin |
|---|---|---|
| IGNYTA INC | Director Técnico/Científico/I+D | 05/02/2014 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular diagnostics for cancer and immunology | Director Técnico/Científico/I+D | - |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Formación de Patrick M. O'Connor.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Selexagen Therapeutics, Inc.
Selexagen Therapeutics, Inc. Selexagen Therapeutics, Inc. is a private company based in San Diego, CA. The company was founded by Jean-Michel Vernier, Patrick M. O'Connor. | |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular diagnostics for cancer and immunology | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
- Bolsa de valores
- Insiders
- Patrick M. O'Connor
